Predictors of outcome in idiopathic rapidly progressive glomerulonephritis (IRPGN).
BACKGROUND
Small vessel vasculitides are known to follow a devastating course towards end-stage renal disease, unless treated with immunosuppressive regiments. We investigated the value of clinical, histological and immunohistochemical parameters as predictors of outcome at diagnosis in patients with pauci immune necrotizing glomerulonephritis.


METHODS
In 34 patients the percentage and evolution stage of crescents, the presence of glomerular necrosis, the degree or severity of arteriosclerosis, as well as the extent of tubulointerstitial infiltration, interstial fibrosis and tubular atrophy were assessed. Monoclonal antibodies were used to identify infiltrating macrophages, alpha-SMA(+) and PCNA(+) cells, the expression of integrins alpha3beta1 and LFA-1beta, the adhesion molecule ICAM-1, the growth factor TGF-beta1 and the terminal complement component C5b-9.


RESULTS
24 pts (70.6%) showed a complete or partial response to the treatment. The follow-up period was 20 +/- 22 months. At multivariate analysis, serum CRP (p = 0.024), the intensity of tubular expression of C5b-9 (p < 0.0001) as well as the extent of glomerular and tubular expression of alpha3beta1 integrin (p = 0.001 and 0.008 respectively) independently predicted the response to treatment. The response rate was better in ANCA(+) pts (p = 0.008). The extent of interstitial infiltrate (p < 0.0001), the severity of tubulointerstitial fibrosis (p < 0.0001) and the severity of tubular TGF-beta1 expression (p < 0.0001) were independent predictors of long term outcome of renal function.


CONCLUSIONS
Patients with ANCA-associated renal vasculitis seem to respond better to the treatment. Acute phase reactants, such as CRP, implying a more intense parenchymal inflammatory reaction, as well as the intensity of the de novo expression of C5b-9 and the glomerular and tubular expression of alpha3beta1 integrin predict the response to therapy. The severity of TIN lesions and of the tubulo-interstitial TGF-beta1 and C5b-9 expression predict an unfavourable outcome.
Alexopoulos
Efstathios
E
Department of Nephrology, Papanikolaou General Hospital, Exohi, Thessaloniki, Greece. nephrol@med.auth.gr
Gionanlis
Lazaros
L
Papayianni
Ekaterini
E
Kokolina
Elizabeth
E
Leontsini
Maria
M
Memmos
Dimitrios
D
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D019268:Antibodies, Antineutrophil Cytoplasmic / Q000097:blood; D002097:C-Reactive Protein / Q000378:metabolism; D015938:Complement Membrane Attack Complex / Q000378:metabolism; D018450:Disease Progression; D005260:Female; D005500:Follow-Up Studies; D005921:Glomerulonephritis / Q000150:complications / Q000473:pathology / Q000503:physiopathology* / Q000628:therapy*; D006801:Humans; D007150:Immunohistochemistry; D039201:Integrin alpha3beta1 / Q000378:metabolism; D007678:Kidney Glomerulus / Q000473:pathology*; D007684:Kidney Tubules / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D011237:Predictive Value of Tests; D011379:Prognosis; D013997:Time Factors; D016896:Treatment Outcome; D014657:Vasculitis / Q000150:complications / Q000276:immunology
D019268:Antibodies, Antineutrophil Cytoplasmic; D015938:Complement Membrane Attack Complex; D039201:Integrin alpha3beta1; D002097:C-Reactive Protein